Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2005
03/16/2005CN1593654A Human lysozyme suppository, preparation method and application
03/16/2005CN1593630A Ointment and its application
03/16/2005CN1593607A Medicinal capsule for treating pelvic inflammatory disease and its preparing process
03/16/2005CN1593605A Dispersible tablet for pelvic inflammatory disease and its preparation
03/16/2005CN1593604A Dispersible tablet for treating mammary glands hyperplasia and its preparing method
03/16/2005CN1593603A Emmeniopathy treating Chinese medicinal capsule and its preparation
03/16/2005CN1593599A Ointment for dispersing breast nodules and preparation method thereof
03/16/2005CN1593596A Compound formulation for treating functional menoxenia and its application in pharmacy
03/16/2005CN1593565A Medicine for treating dysmenorrhea and its preparing method
03/16/2005CN1593555A Indiscerptible and built in type Chinese traditional preparation for gynecopathy and its preparation process
03/16/2005CN1593543A Method for preparing compound Chinese medicinal tonifying liquor
03/16/2005CN1593533A 'Huahong' dispersible tablet for treating gynecological inflammation and its preparing method
03/16/2005CN1593531A Angelica and herbaceous peony root contained capsule for regulating menstruation and its preparation process
03/16/2005CN1593527A Dispersible tablet of 'Duyiwei' and its preparing method
03/16/2005CN1593526A Chinese herbal medicinal injection for treating animal mastitis and its preparing method
03/16/2005CN1593524A Mastopathia treating Chinese traditional medicinal tablet and its preparation process
03/16/2005CN1593519A Method for preparing a gynecopathy treating medicine
03/16/2005CN1593518A Method for preparing a gynecopathy treating medicine
03/16/2005CN1593517A Method for preparing a gynecopathy treating medicine
03/16/2005CN1593516A Method for preparing a gynecopathy treating medicine
03/16/2005CN1593515A Method for preparing a gynecopathy treating medicine
03/16/2005CN1593514A Method for preparing a gynecopathy treating medicine
03/16/2005CN1593510A Method for preparing Chinese medicinal formulation of dog button
03/16/2005CN1593502A Snake slough pills and its prescription
03/16/2005CN1593500A Kidney benefiting, Chong collateral reinforcing and menstruation regulating hemostat
03/16/2005CN1593499A Medicine for treating boil, acute mastitis and acute inflammation
03/16/2005CN1593451A Externally applied medicine for promoting male erection
03/16/2005CN1593443A Medical phytoestrogen
03/16/2005CN1593408A Alkaloids sophora flavescen pellicle and its preparation process
03/16/2005CN1593407A Matrine pellicle and its preparation process
03/16/2005CN1593399A Application of compound laetispicine in the process for preparing pharmaceutical composition
03/16/2005CN1593396A Liquor for increasing cow born ratio and its manufacturing method
03/16/2005CN1593386A Temperature sensitive gel formulation for in situ vagina uses
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1192785C Haemostatic 'Gonghuan' tablet and preparing process
03/16/2005CN1192784C Use of pubescent holly root extract in preparing erection disfunction treating drug
03/16/2005CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them
03/15/2005US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
03/15/2005US6867003 Grb14, Grb14 fusion proteins, and screening methods
03/15/2005US6866872 Withania somnifera Dunal extracts for increasing male sperm count
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/15/2005CA2191769C Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
03/10/2005WO2005021016A1 A pharmaceutical composition for treating hypermenorrhea and preparation method thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054593 New drug
03/10/2005US20050054576 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005CA2535522A1 Fsh glycosylation mutant
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512687A1 Piperazines as oxytocin agonists
03/09/2005EP1512016A1 Screening method and anti-tumor drug candidate obtained therefrom
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511537A2 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
03/09/2005EP1511514A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
03/09/2005EP1511497A1 Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a serm
03/09/2005EP1511495A1 Progestagenic dosage units
03/09/2005EP1511489A1 New pharmaceutical compositions containing flibanserin polymorph a
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1255552B1 Prostaglandin compositions for the treatment for male erectile dysfunction
03/09/2005EP1137423B1 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
03/09/2005EP0876612B1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
03/09/2005CN1592745A Therapeutic chromone compounds
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
03/09/2005CN1592600A Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1589897A Biological immune preparation for treating dairy cattle clinical mamitis and its manufacturing method
03/09/2005CN1589894A Medicinal composition for treating parafunctional metrorrhagia and its preparation method
03/09/2005CN1589884A External use Chinese medicinal lotion for treating gynecopathy inflammation
03/09/2005CN1589880A Traditional Chinese modicine for treating gynecopathy and its preparation method
03/09/2005CN1589877A Ready prepared Chinese medicine for treating angeitis and preparation process
03/09/2005CN1589866A External use Chinese medicinal preparation for treating gynecopathy and its manufacturing method
03/09/2005CN1589848A Anti inflammatory bacteria inhibiting medicinal composition and its preparation method
03/09/2005CN1589820A Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
03/09/2005CN1589801A Progesterone liquid capsule and its preparation method
03/09/2005CN1589786A Composite effervescent preparation containing soya isoflavone
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1191849C Chinese medicine for treating breast disease
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer